nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—coronary artery disease	0.301	1	CbGaD
Cefotetan—ALB—Pitavastatin—coronary artery disease	0.0905	0.19	CbGbCtD
Cefotetan—ALB—Valsartan—coronary artery disease	0.0881	0.185	CbGbCtD
Cefotetan—ALB—Rosuvastatin—coronary artery disease	0.0667	0.14	CbGbCtD
Cefotetan—ALB—Acetylsalicylic acid—coronary artery disease	0.065	0.136	CbGbCtD
Cefotetan—ALB—Captopril—coronary artery disease	0.0642	0.135	CbGbCtD
Cefotetan—ALB—Furosemide—coronary artery disease	0.0516	0.108	CbGbCtD
Cefotetan—ALB—Losartan—coronary artery disease	0.0506	0.106	CbGbCtD
Cefotetan—Cefazolin—PON1—coronary artery disease	0.00107	0.488	CrCbGaD
Cefotetan—Cefpiramide—ALB—coronary artery disease	0.000283	0.129	CrCbGaD
Cefotetan—Leukopenia—Furosemide—coronary artery disease	0.000257	0.00164	CcSEcCtD
Cefotetan—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000256	0.00164	CcSEcCtD
Cefotetan—Abdominal pain—Fenofibrate—coronary artery disease	0.000256	0.00164	CcSEcCtD
Cefotetan—Body temperature increased—Fenofibrate—coronary artery disease	0.000256	0.00164	CcSEcCtD
Cefotetan—Discomfort—Captopril—coronary artery disease	0.000255	0.00164	CcSEcCtD
Cefotetan—Diarrhoea—Rosuvastatin—coronary artery disease	0.000255	0.00163	CcSEcCtD
Cefotetan—Anaphylactic shock—Telmisartan—coronary artery disease	0.000255	0.00163	CcSEcCtD
Cefotetan—Thrombocytopenia—Trandolapril—coronary artery disease	0.000254	0.00163	CcSEcCtD
Cefotetan—Gastrointestinal pain—Ezetimibe—coronary artery disease	0.000253	0.00162	CcSEcCtD
Cefotetan—Thrombocytopenia—Enalapril—coronary artery disease	0.000253	0.00162	CcSEcCtD
Cefotetan—Urticaria—Clopidogrel—coronary artery disease	0.000253	0.00162	CcSEcCtD
Cefotetan—Nausea—Gemfibrozil—coronary artery disease	0.000252	0.00161	CcSEcCtD
Cefotetan—Abdominal pain—Clopidogrel—coronary artery disease	0.000251	0.00161	CcSEcCtD
Cefotetan—Body temperature increased—Clopidogrel—coronary artery disease	0.000251	0.00161	CcSEcCtD
Cefotetan—Urticaria—Lovastatin—coronary artery disease	0.000251	0.00161	CcSEcCtD
Cefotetan—Abdominal pain—Lovastatin—coronary artery disease	0.00025	0.0016	CcSEcCtD
Cefotetan—Body temperature increased—Lovastatin—coronary artery disease	0.00025	0.0016	CcSEcCtD
Cefotetan—Thrombocytopenia—Telmisartan—coronary artery disease	0.00025	0.0016	CcSEcCtD
Cefotetan—Gastrointestinal pain—Eplerenone—coronary artery disease	0.000248	0.00159	CcSEcCtD
Cefotetan—Discomfort—Perindopril—coronary artery disease	0.000248	0.00159	CcSEcCtD
Cefotetan—Anaphylactic shock—Captopril—coronary artery disease	0.000248	0.00159	CcSEcCtD
Cefotetan—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000248	0.00159	CcSEcCtD
Cefotetan—Leukopenia—Losartan—coronary artery disease	0.000248	0.00159	CcSEcCtD
Cefotetan—Cefonicid—ALB—coronary artery disease	0.000247	0.112	CrCbGaD
Cefotetan—Urticaria—Ezetimibe—coronary artery disease	0.000246	0.00158	CcSEcCtD
Cefotetan—Nausea—Ticagrelor—coronary artery disease	0.000246	0.00158	CcSEcCtD
Cefotetan—Body temperature increased—Ezetimibe—coronary artery disease	0.000245	0.00157	CcSEcCtD
Cefotetan—Abdominal pain—Ezetimibe—coronary artery disease	0.000245	0.00157	CcSEcCtD
Cefotetan—Thrombocytopenia—Captopril—coronary artery disease	0.000243	0.00156	CcSEcCtD
Cefotetan—Gastrointestinal pain—Simvastatin—coronary artery disease	0.000242	0.00155	CcSEcCtD
Cefotetan—Anaphylactic shock—Perindopril—coronary artery disease	0.000241	0.00154	CcSEcCtD
Cefotetan—Abdominal pain—Eplerenone—coronary artery disease	0.00024	0.00154	CcSEcCtD
Cefotetan—Body temperature increased—Eplerenone—coronary artery disease	0.00024	0.00154	CcSEcCtD
Cefotetan—Hypersensitivity—Fenofibrate—coronary artery disease	0.000238	0.00153	CcSEcCtD
Cefotetan—Thrombocytopenia—Perindopril—coronary artery disease	0.000236	0.00151	CcSEcCtD
Cefotetan—Rash—Rosuvastatin—coronary artery disease	0.000235	0.00151	CcSEcCtD
Cefotetan—Dermatitis—Rosuvastatin—coronary artery disease	0.000235	0.0015	CcSEcCtD
Cefotetan—Urticaria—Simvastatin—coronary artery disease	0.000235	0.0015	CcSEcCtD
Cefotetan—Hypersensitivity—Clopidogrel—coronary artery disease	0.000234	0.0015	CcSEcCtD
Cefotetan—Anaphylactic shock—Furosemide—coronary artery disease	0.000234	0.0015	CcSEcCtD
Cefotetan—Abdominal pain—Simvastatin—coronary artery disease	0.000234	0.0015	CcSEcCtD
Cefotetan—Body temperature increased—Simvastatin—coronary artery disease	0.000234	0.0015	CcSEcCtD
Cefotetan—Erythema multiforme—Lisinopril—coronary artery disease	0.000234	0.0015	CcSEcCtD
Cefotetan—Hypersensitivity—Lovastatin—coronary artery disease	0.000233	0.00149	CcSEcCtD
Cefotetan—Discomfort—Losartan—coronary artery disease	0.000233	0.00149	CcSEcCtD
Cefotetan—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00023	0.00148	CcSEcCtD
Cefotetan—Thrombocytopenia—Furosemide—coronary artery disease	0.000229	0.00147	CcSEcCtD
Cefotetan—Pruritus—Fenofibrate—coronary artery disease	0.000229	0.00147	CcSEcCtD
Cefotetan—Rash—Acetylsalicylic acid—coronary artery disease	0.000228	0.00146	CcSEcCtD
Cefotetan—Hypersensitivity—Ezetimibe—coronary artery disease	0.000228	0.00146	CcSEcCtD
Cefotetan—Gastrointestinal pain—Valsartan—coronary artery disease	0.000228	0.00146	CcSEcCtD
Cefotetan—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000228	0.00146	CcSEcCtD
Cefotetan—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000227	0.00146	CcSEcCtD
Cefotetan—Anaphylactic shock—Losartan—coronary artery disease	0.000226	0.00145	CcSEcCtD
Cefotetan—Pruritus—Clopidogrel—coronary artery disease	0.000225	0.00144	CcSEcCtD
Cefotetan—Pruritus—Lovastatin—coronary artery disease	0.000224	0.00143	CcSEcCtD
Cefotetan—Gastrointestinal pain—Niacin—coronary artery disease	0.000222	0.00142	CcSEcCtD
Cefotetan—Urticaria—Valsartan—coronary artery disease	0.000222	0.00142	CcSEcCtD
Cefotetan—Nausea—Rosuvastatin—coronary artery disease	0.000221	0.00142	CcSEcCtD
Cefotetan—Diarrhoea—Fenofibrate—coronary artery disease	0.000221	0.00142	CcSEcCtD
Cefotetan—Thrombocytopenia—Losartan—coronary artery disease	0.000221	0.00142	CcSEcCtD
Cefotetan—Urticaria—Olmesartan—coronary artery disease	0.000221	0.00141	CcSEcCtD
Cefotetan—Abdominal pain—Valsartan—coronary artery disease	0.000221	0.00141	CcSEcCtD
Cefotetan—Body temperature increased—Olmesartan—coronary artery disease	0.00022	0.00141	CcSEcCtD
Cefotetan—Abdominal pain—Olmesartan—coronary artery disease	0.00022	0.00141	CcSEcCtD
Cefotetan—Pruritus—Ezetimibe—coronary artery disease	0.000219	0.0014	CcSEcCtD
Cefotetan—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000218	0.0014	CcSEcCtD
Cefotetan—Hypersensitivity—Simvastatin—coronary artery disease	0.000218	0.0014	CcSEcCtD
Cefotetan—Diarrhoea—Clopidogrel—coronary artery disease	0.000218	0.00139	CcSEcCtD
Cefotetan—Cefmetazole—ALB—coronary artery disease	0.000217	0.0988	CrCbGaD
Cefotetan—Diarrhoea—Lovastatin—coronary artery disease	0.000216	0.00139	CcSEcCtD
Cefotetan—Urticaria—Niacin—coronary artery disease	0.000216	0.00138	CcSEcCtD
Cefotetan—Nausea—Acetylsalicylic acid—coronary artery disease	0.000215	0.00138	CcSEcCtD
Cefotetan—Pruritus—Eplerenone—coronary artery disease	0.000215	0.00138	CcSEcCtD
Cefotetan—Abdominal pain—Niacin—coronary artery disease	0.000215	0.00137	CcSEcCtD
Cefotetan—Body temperature increased—Niacin—coronary artery disease	0.000215	0.00137	CcSEcCtD
Cefotetan—Leukopenia—Ramipril—coronary artery disease	0.000212	0.00136	CcSEcCtD
Cefotetan—Urticaria—Pravastatin—coronary artery disease	0.000212	0.00136	CcSEcCtD
Cefotetan—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000212	0.00136	CcSEcCtD
Cefotetan—Diarrhoea—Ezetimibe—coronary artery disease	0.000212	0.00136	CcSEcCtD
Cefotetan—Gastrointestinal pain—Enalapril—coronary artery disease	0.000211	0.00135	CcSEcCtD
Cefotetan—Abdominal pain—Pravastatin—coronary artery disease	0.000211	0.00135	CcSEcCtD
Cefotetan—Body temperature increased—Pravastatin—coronary artery disease	0.000211	0.00135	CcSEcCtD
Cefotetan—Pruritus—Simvastatin—coronary artery disease	0.000209	0.00134	CcSEcCtD
Cefotetan—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000208	0.00134	CcSEcCtD
Cefotetan—Diarrhoea—Eplerenone—coronary artery disease	0.000208	0.00133	CcSEcCtD
Cefotetan—Urticaria—Trandolapril—coronary artery disease	0.000206	0.00132	CcSEcCtD
Cefotetan—Vomiting—Fenofibrate—coronary artery disease	0.000206	0.00132	CcSEcCtD
Cefotetan—Hypersensitivity—Valsartan—coronary artery disease	0.000206	0.00132	CcSEcCtD
Cefotetan—Convulsion—Ramipril—coronary artery disease	0.000205	0.00132	CcSEcCtD
Cefotetan—Urticaria—Enalapril—coronary artery disease	0.000205	0.00132	CcSEcCtD
Cefotetan—Abdominal pain—Trandolapril—coronary artery disease	0.000205	0.00131	CcSEcCtD
Cefotetan—Body temperature increased—Trandolapril—coronary artery disease	0.000205	0.00131	CcSEcCtD
Cefotetan—Abdominal pain—Enalapril—coronary artery disease	0.000204	0.00131	CcSEcCtD
Cefotetan—Body temperature increased—Enalapril—coronary artery disease	0.000204	0.00131	CcSEcCtD
Cefotetan—Rash—Fenofibrate—coronary artery disease	0.000204	0.00131	CcSEcCtD
Cefotetan—Dermatitis—Fenofibrate—coronary artery disease	0.000204	0.00131	CcSEcCtD
Cefotetan—Gastrointestinal pain—Captopril—coronary artery disease	0.000203	0.0013	CcSEcCtD
Cefotetan—Urticaria—Telmisartan—coronary artery disease	0.000202	0.0013	CcSEcCtD
Cefotetan—Vomiting—Clopidogrel—coronary artery disease	0.000202	0.0013	CcSEcCtD
Cefotetan—Diarrhoea—Simvastatin—coronary artery disease	0.000202	0.0013	CcSEcCtD
Cefotetan—Abdominal pain—Telmisartan—coronary artery disease	0.000201	0.00129	CcSEcCtD
Cefotetan—Body temperature increased—Telmisartan—coronary artery disease	0.000201	0.00129	CcSEcCtD
Cefotetan—Vomiting—Lovastatin—coronary artery disease	0.000201	0.00129	CcSEcCtD
Cefotetan—Rash—Clopidogrel—coronary artery disease	0.000201	0.00129	CcSEcCtD
Cefotetan—Dermatitis—Clopidogrel—coronary artery disease	0.0002	0.00128	CcSEcCtD
Cefotetan—Hypersensitivity—Niacin—coronary artery disease	0.0002	0.00128	CcSEcCtD
Cefotetan—Discomfort—Ramipril—coronary artery disease	0.000199	0.00128	CcSEcCtD
Cefotetan—Rash—Lovastatin—coronary artery disease	0.000199	0.00128	CcSEcCtD
Cefotetan—Dermatitis—Lovastatin—coronary artery disease	0.000199	0.00128	CcSEcCtD
Cefotetan—Pruritus—Valsartan—coronary artery disease	0.000197	0.00127	CcSEcCtD
Cefotetan—Vomiting—Ezetimibe—coronary artery disease	0.000197	0.00126	CcSEcCtD
Cefotetan—Hypersensitivity—Pravastatin—coronary artery disease	0.000197	0.00126	CcSEcCtD
Cefotetan—Gastrointestinal pain—Perindopril—coronary artery disease	0.000197	0.00126	CcSEcCtD
Cefotetan—Pruritus—Olmesartan—coronary artery disease	0.000197	0.00126	CcSEcCtD
Cefotetan—Body temperature increased—Captopril—coronary artery disease	0.000196	0.00126	CcSEcCtD
Cefotetan—Abdominal pain—Captopril—coronary artery disease	0.000196	0.00126	CcSEcCtD
Cefotetan—Rash—Ezetimibe—coronary artery disease	0.000195	0.00125	CcSEcCtD
Cefotetan—Dermatitis—Ezetimibe—coronary artery disease	0.000195	0.00125	CcSEcCtD
Cefotetan—Discomfort—Timolol—coronary artery disease	0.000195	0.00125	CcSEcCtD
Cefotetan—Anaphylactic shock—Ramipril—coronary artery disease	0.000194	0.00124	CcSEcCtD
Cefotetan—Vomiting—Eplerenone—coronary artery disease	0.000193	0.00124	CcSEcCtD
Cefotetan—Leukopenia—Lisinopril—coronary artery disease	0.000193	0.00123	CcSEcCtD
Cefotetan—Nausea—Fenofibrate—coronary artery disease	0.000192	0.00123	CcSEcCtD
Cefotetan—Pruritus—Niacin—coronary artery disease	0.000192	0.00123	CcSEcCtD
Cefotetan—Gastrointestinal pain—Furosemide—coronary artery disease	0.000191	0.00123	CcSEcCtD
Cefotetan—Rash—Eplerenone—coronary artery disease	0.000191	0.00123	CcSEcCtD
Cefotetan—Urticaria—Perindopril—coronary artery disease	0.000191	0.00122	CcSEcCtD
Cefotetan—Hypersensitivity—Trandolapril—coronary artery disease	0.000191	0.00122	CcSEcCtD
Cefotetan—Dermatitis—Eplerenone—coronary artery disease	0.000191	0.00122	CcSEcCtD
Cefotetan—Diarrhoea—Valsartan—coronary artery disease	0.000191	0.00122	CcSEcCtD
Cefotetan—Hypersensitivity—Enalapril—coronary artery disease	0.00019	0.00122	CcSEcCtD
Cefotetan—Abdominal pain—Perindopril—coronary artery disease	0.00019	0.00122	CcSEcCtD
Cefotetan—Body temperature increased—Perindopril—coronary artery disease	0.00019	0.00122	CcSEcCtD
Cefotetan—Diarrhoea—Olmesartan—coronary artery disease	0.00019	0.00122	CcSEcCtD
Cefotetan—Thrombocytopenia—Ramipril—coronary artery disease	0.00019	0.00121	CcSEcCtD
Cefotetan—Anaphylactic shock—Timolol—coronary artery disease	0.000189	0.00121	CcSEcCtD
Cefotetan—Pruritus—Pravastatin—coronary artery disease	0.000189	0.00121	CcSEcCtD
Cefotetan—Nausea—Clopidogrel—coronary artery disease	0.000189	0.00121	CcSEcCtD
Cefotetan—Vomiting—Simvastatin—coronary artery disease	0.000188	0.0012	CcSEcCtD
Cefotetan—Hypersensitivity—Telmisartan—coronary artery disease	0.000188	0.0012	CcSEcCtD
Cefotetan—Nausea—Lovastatin—coronary artery disease	0.000188	0.0012	CcSEcCtD
Cefotetan—Rash—Simvastatin—coronary artery disease	0.000186	0.00119	CcSEcCtD
Cefotetan—Dermatitis—Simvastatin—coronary artery disease	0.000186	0.00119	CcSEcCtD
Cefotetan—Urticaria—Furosemide—coronary artery disease	0.000186	0.00119	CcSEcCtD
Cefotetan—Diarrhoea—Niacin—coronary artery disease	0.000186	0.00119	CcSEcCtD
Cefotetan—Body temperature increased—Furosemide—coronary artery disease	0.000185	0.00119	CcSEcCtD
Cefotetan—Abdominal pain—Furosemide—coronary artery disease	0.000185	0.00119	CcSEcCtD
Cefotetan—Gastrointestinal pain—Losartan—coronary artery disease	0.000185	0.00118	CcSEcCtD
Cefotetan—Nausea—Ezetimibe—coronary artery disease	0.000184	0.00118	CcSEcCtD
Cefotetan—Pruritus—Trandolapril—coronary artery disease	0.000184	0.00118	CcSEcCtD
Cefotetan—Pruritus—Enalapril—coronary artery disease	0.000183	0.00117	CcSEcCtD
Cefotetan—Diarrhoea—Pravastatin—coronary artery disease	0.000183	0.00117	CcSEcCtD
Cefotetan—Discomfort—Lisinopril—coronary artery disease	0.000181	0.00116	CcSEcCtD
Cefotetan—Pruritus—Telmisartan—coronary artery disease	0.00018	0.00116	CcSEcCtD
Cefotetan—Nausea—Eplerenone—coronary artery disease	0.00018	0.00115	CcSEcCtD
Cefotetan—Urticaria—Losartan—coronary artery disease	0.000179	0.00115	CcSEcCtD
Cefotetan—Abdominal pain—Losartan—coronary artery disease	0.000178	0.00114	CcSEcCtD
Cefotetan—Body temperature increased—Losartan—coronary artery disease	0.000178	0.00114	CcSEcCtD
Cefotetan—Diarrhoea—Trandolapril—coronary artery disease	0.000178	0.00114	CcSEcCtD
Cefotetan—Vomiting—Valsartan—coronary artery disease	0.000177	0.00114	CcSEcCtD
Cefotetan—Diarrhoea—Enalapril—coronary artery disease	0.000177	0.00113	CcSEcCtD
Cefotetan—Vomiting—Olmesartan—coronary artery disease	0.000177	0.00113	CcSEcCtD
Cefotetan—Rash—Valsartan—coronary artery disease	0.000176	0.00113	CcSEcCtD
Cefotetan—Dermatitis—Valsartan—coronary artery disease	0.000176	0.00113	CcSEcCtD
Cefotetan—Nausea—Simvastatin—coronary artery disease	0.000176	0.00112	CcSEcCtD
Cefotetan—Anaphylactic shock—Lisinopril—coronary artery disease	0.000176	0.00112	CcSEcCtD
Cefotetan—Pruritus—Captopril—coronary artery disease	0.000175	0.00112	CcSEcCtD
Cefotetan—Rash—Olmesartan—coronary artery disease	0.000175	0.00112	CcSEcCtD
Cefotetan—Dermatitis—Olmesartan—coronary artery disease	0.000175	0.00112	CcSEcCtD
Cefotetan—Diarrhoea—Telmisartan—coronary artery disease	0.000174	0.00112	CcSEcCtD
Cefotetan—Vomiting—Niacin—coronary artery disease	0.000173	0.00111	CcSEcCtD
Cefotetan—Hypersensitivity—Furosemide—coronary artery disease	0.000172	0.0011	CcSEcCtD
Cefotetan—Thrombocytopenia—Lisinopril—coronary artery disease	0.000172	0.0011	CcSEcCtD
Cefotetan—Rash—Niacin—coronary artery disease	0.000171	0.0011	CcSEcCtD
Cefotetan—Dermatitis—Niacin—coronary artery disease	0.000171	0.0011	CcSEcCtD
Cefotetan—Pruritus—Perindopril—coronary artery disease	0.00017	0.00109	CcSEcCtD
Cefotetan—Vomiting—Pravastatin—coronary artery disease	0.00017	0.00109	CcSEcCtD
Cefotetan—Diarrhoea—Captopril—coronary artery disease	0.00017	0.00109	CcSEcCtD
Cefotetan—Rash—Pravastatin—coronary artery disease	0.000168	0.00108	CcSEcCtD
Cefotetan—Dermatitis—Pravastatin—coronary artery disease	0.000168	0.00108	CcSEcCtD
Cefotetan—Hypersensitivity—Losartan—coronary artery disease	0.000166	0.00107	CcSEcCtD
Cefotetan—Nausea—Valsartan—coronary artery disease	0.000166	0.00106	CcSEcCtD
Cefotetan—Pruritus—Furosemide—coronary artery disease	0.000166	0.00106	CcSEcCtD
Cefotetan—Nausea—Olmesartan—coronary artery disease	0.000165	0.00106	CcSEcCtD
Cefotetan—Vomiting—Trandolapril—coronary artery disease	0.000165	0.00106	CcSEcCtD
Cefotetan—Diarrhoea—Perindopril—coronary artery disease	0.000165	0.00106	CcSEcCtD
Cefotetan—Vomiting—Enalapril—coronary artery disease	0.000164	0.00105	CcSEcCtD
Cefotetan—Rash—Trandolapril—coronary artery disease	0.000164	0.00105	CcSEcCtD
Cefotetan—Dermatitis—Trandolapril—coronary artery disease	0.000163	0.00105	CcSEcCtD
Cefotetan—Rash—Enalapril—coronary artery disease	0.000163	0.00104	CcSEcCtD
Cefotetan—Dermatitis—Enalapril—coronary artery disease	0.000163	0.00104	CcSEcCtD
Cefotetan—Vomiting—Telmisartan—coronary artery disease	0.000162	0.00104	CcSEcCtD
Cefotetan—Nausea—Niacin—coronary artery disease	0.000161	0.00103	CcSEcCtD
Cefotetan—Rash—Telmisartan—coronary artery disease	0.000161	0.00103	CcSEcCtD
Cefotetan—Dermatitis—Telmisartan—coronary artery disease	0.000161	0.00103	CcSEcCtD
Cefotetan—Diarrhoea—Furosemide—coronary artery disease	0.00016	0.00103	CcSEcCtD
Cefotetan—Pruritus—Losartan—coronary artery disease	0.00016	0.00102	CcSEcCtD
Cefotetan—Nausea—Pravastatin—coronary artery disease	0.000159	0.00102	CcSEcCtD
Cefotetan—Gastrointestinal pain—Ramipril—coronary artery disease	0.000158	0.00101	CcSEcCtD
Cefotetan—Vomiting—Captopril—coronary artery disease	0.000158	0.00101	CcSEcCtD
Cefotetan—Rash—Captopril—coronary artery disease	0.000156	0.001	CcSEcCtD
Cefotetan—Dermatitis—Captopril—coronary artery disease	0.000156	0.001	CcSEcCtD
Cefotetan—Gastrointestinal pain—Timolol—coronary artery disease	0.000155	0.000991	CcSEcCtD
Cefotetan—Diarrhoea—Losartan—coronary artery disease	0.000154	0.00099	CcSEcCtD
Cefotetan—Nausea—Trandolapril—coronary artery disease	0.000154	0.000988	CcSEcCtD
Cefotetan—Urticaria—Ramipril—coronary artery disease	0.000154	0.000985	CcSEcCtD
Cefotetan—Nausea—Enalapril—coronary artery disease	0.000154	0.000984	CcSEcCtD
Cefotetan—Vomiting—Perindopril—coronary artery disease	0.000153	0.00098	CcSEcCtD
Cefotetan—Abdominal pain—Ramipril—coronary artery disease	0.000153	0.00098	CcSEcCtD
Cefotetan—Body temperature increased—Ramipril—coronary artery disease	0.000153	0.00098	CcSEcCtD
Cefotetan—Rash—Perindopril—coronary artery disease	0.000152	0.000972	CcSEcCtD
Cefotetan—Dermatitis—Perindopril—coronary artery disease	0.000152	0.000971	CcSEcCtD
Cefotetan—Nausea—Telmisartan—coronary artery disease	0.000151	0.00097	CcSEcCtD
Cefotetan—Urticaria—Timolol—coronary artery disease	0.00015	0.000963	CcSEcCtD
Cefotetan—Body temperature increased—Timolol—coronary artery disease	0.00015	0.000958	CcSEcCtD
Cefotetan—Abdominal pain—Timolol—coronary artery disease	0.00015	0.000958	CcSEcCtD
Cefotetan—Vomiting—Furosemide—coronary artery disease	0.000149	0.000953	CcSEcCtD
Cefotetan—Rash—Furosemide—coronary artery disease	0.000148	0.000945	CcSEcCtD
Cefotetan—Dermatitis—Furosemide—coronary artery disease	0.000147	0.000944	CcSEcCtD
Cefotetan—Nausea—Captopril—coronary artery disease	0.000147	0.000943	CcSEcCtD
Cefotetan—Cefoperazone—ALB—coronary artery disease	0.000145	0.0661	CrCbGaD
Cefotetan—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000144	0.00092	CcSEcCtD
Cefotetan—Vomiting—Losartan—coronary artery disease	0.000144	0.00092	CcSEcCtD
Cefotetan—Nausea—Perindopril—coronary artery disease	0.000143	0.000916	CcSEcCtD
Cefotetan—Hypersensitivity—Ramipril—coronary artery disease	0.000143	0.000914	CcSEcCtD
Cefotetan—Rash—Losartan—coronary artery disease	0.000142	0.000912	CcSEcCtD
Cefotetan—Dermatitis—Losartan—coronary artery disease	0.000142	0.000911	CcSEcCtD
Cefotetan—Urticaria—Lisinopril—coronary artery disease	0.000139	0.000894	CcSEcCtD
Cefotetan—Hypersensitivity—Timolol—coronary artery disease	0.000139	0.000893	CcSEcCtD
Cefotetan—Nausea—Furosemide—coronary artery disease	0.000139	0.00089	CcSEcCtD
Cefotetan—Abdominal pain—Lisinopril—coronary artery disease	0.000139	0.000889	CcSEcCtD
Cefotetan—Body temperature increased—Lisinopril—coronary artery disease	0.000139	0.000889	CcSEcCtD
Cefotetan—Pruritus—Ramipril—coronary artery disease	0.000137	0.000877	CcSEcCtD
Cefotetan—Nausea—Losartan—coronary artery disease	0.000134	0.000859	CcSEcCtD
Cefotetan—Pruritus—Timolol—coronary artery disease	0.000134	0.000858	CcSEcCtD
Cefotetan—Diarrhoea—Ramipril—coronary artery disease	0.000132	0.000849	CcSEcCtD
Cefotetan—Diarrhoea—Timolol—coronary artery disease	0.000129	0.00083	CcSEcCtD
Cefotetan—Hypersensitivity—Lisinopril—coronary artery disease	0.000129	0.000829	CcSEcCtD
Cefotetan—Pruritus—Lisinopril—coronary artery disease	0.000124	0.000796	CcSEcCtD
Cefotetan—Vomiting—Ramipril—coronary artery disease	0.000123	0.000789	CcSEcCtD
Cefotetan—Rash—Ramipril—coronary artery disease	0.000122	0.000782	CcSEcCtD
Cefotetan—Dermatitis—Ramipril—coronary artery disease	0.000122	0.000781	CcSEcCtD
Cefotetan—Vomiting—Timolol—coronary artery disease	0.00012	0.000771	CcSEcCtD
Cefotetan—Diarrhoea—Lisinopril—coronary artery disease	0.00012	0.00077	CcSEcCtD
Cefotetan—Cefazolin—ALB—coronary artery disease	0.00012	0.0543	CrCbGaD
Cefotetan—Rash—Timolol—coronary artery disease	0.000119	0.000764	CcSEcCtD
Cefotetan—Dermatitis—Timolol—coronary artery disease	0.000119	0.000764	CcSEcCtD
Cefotetan—Nausea—Ramipril—coronary artery disease	0.000115	0.000737	CcSEcCtD
Cefotetan—Ceftriaxone—ALB—coronary artery disease	0.000113	0.0515	CrCbGaD
Cefotetan—Nausea—Timolol—coronary artery disease	0.000112	0.00072	CcSEcCtD
Cefotetan—Vomiting—Lisinopril—coronary artery disease	0.000112	0.000715	CcSEcCtD
Cefotetan—Rash—Lisinopril—coronary artery disease	0.000111	0.000709	CcSEcCtD
Cefotetan—Dermatitis—Lisinopril—coronary artery disease	0.000111	0.000709	CcSEcCtD
Cefotetan—Nausea—Lisinopril—coronary artery disease	0.000104	0.000668	CcSEcCtD
Cefotetan—ALB—Hemostasis—PPBP—coronary artery disease	6.73e-05	0.00105	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITGA2B—coronary artery disease	6.62e-05	0.00104	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	6.59e-05	0.00103	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—KNG1—coronary artery disease	6.58e-05	0.00103	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HK2—coronary artery disease	6.53e-05	0.00102	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	6.46e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	6.46e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PTGS2—coronary artery disease	6.45e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ATP2B1—coronary artery disease	6.42e-05	0.001	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PLG—coronary artery disease	6.37e-05	0.000997	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	6.34e-05	0.000992	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F3—coronary artery disease	6.32e-05	0.00099	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CKMT1B—coronary artery disease	6.27e-05	0.000981	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	6.26e-05	0.00098	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP4A—coronary artery disease	6.26e-05	0.00098	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ANGPT2—coronary artery disease	6.15e-05	0.000963	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SELL—coronary artery disease	6.15e-05	0.000963	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PRKCE—coronary artery disease	6.13e-05	0.000959	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SOD1—coronary artery disease	6.11e-05	0.000956	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL1B—coronary artery disease	6e-05	0.00094	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F5—coronary artery disease	6e-05	0.000938	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SELP—coronary artery disease	6e-05	0.000938	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	5.93e-05	0.000928	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	5.93e-05	0.000928	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SLC8A1—coronary artery disease	5.92e-05	0.000927	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GATA4—coronary artery disease	5.85e-05	0.000916	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	5.76e-05	0.000901	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	5.76e-05	0.000901	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—coronary artery disease	5.65e-05	0.000884	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	5.55e-05	0.000869	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	5.55e-05	0.000869	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—P2RY12—coronary artery disease	5.54e-05	0.000867	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—VEGFA—coronary artery disease	5.49e-05	0.000859	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TNF—coronary artery disease	5.48e-05	0.000858	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—HGF—coronary artery disease	5.48e-05	0.000858	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	5.46e-05	0.000854	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	5.46e-05	0.000854	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	5.46e-05	0.000854	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL6—coronary artery disease	5.44e-05	0.000851	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CSF2—coronary artery disease	5.42e-05	0.000848	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	5.39e-05	0.000844	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	5.39e-05	0.000844	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—THBD—coronary artery disease	5.38e-05	0.000842	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GNA12—coronary artery disease	5.38e-05	0.000842	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	5.33e-05	0.000834	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—coronary artery disease	5.23e-05	0.000818	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	5.21e-05	0.000815	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—ITGB3—coronary artery disease	5.2e-05	0.000813	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	5.13e-05	0.000802	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG5—coronary artery disease	5.13e-05	0.000802	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HK1—coronary artery disease	5.13e-05	0.000802	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CD36—coronary artery disease	5.11e-05	0.0008	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CKM—coronary artery disease	5.11e-05	0.000799	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPAP2B—coronary artery disease	5.11e-05	0.000799	CbGpPWpGaD
Cefotetan—ALB—Metabolism—UQCRFS1—coronary artery disease	5.11e-05	0.000799	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SELE—coronary artery disease	5.1e-05	0.000798	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—TGFB1—coronary artery disease	5.04e-05	0.000788	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	4.99e-05	0.000781	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PRKCD—coronary artery disease	4.96e-05	0.000776	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ALDOA—coronary artery disease	4.94e-05	0.000773	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	4.9e-05	0.000766	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	4.81e-05	0.000752	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—coronary artery disease	4.8e-05	0.000751	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CKMT2—coronary artery disease	4.75e-05	0.000743	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDH6A1—coronary artery disease	4.75e-05	0.000743	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SULT4A1—coronary artery disease	4.75e-05	0.000743	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PYGM—coronary artery disease	4.75e-05	0.000743	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PDK4—coronary artery disease	4.75e-05	0.000743	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CRK—coronary artery disease	4.6e-05	0.00072	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SH2B3—coronary artery disease	4.54e-05	0.000711	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ATP2A2—coronary artery disease	4.54e-05	0.000711	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VWF—coronary artery disease	4.54e-05	0.000711	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—APOA1—coronary artery disease	4.46e-05	0.000698	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL6—coronary artery disease	4.43e-05	0.000693	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—MAPK14—coronary artery disease	4.39e-05	0.000687	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—TNF—coronary artery disease	4.36e-05	0.000682	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SPARC—coronary artery disease	4.33e-05	0.000678	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F2R—coronary artery disease	4.33e-05	0.000678	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F7—coronary artery disease	4.33e-05	0.000678	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—F2—coronary artery disease	4.25e-05	0.000666	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—FN1—coronary artery disease	4.25e-05	0.000666	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IRF1—coronary artery disease	4.24e-05	0.000664	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FGB—coronary artery disease	4.24e-05	0.000664	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LDHA—coronary artery disease	4.23e-05	0.000662	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMGCS2—coronary artery disease	4.23e-05	0.000662	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GYG1—coronary artery disease	4.23e-05	0.000662	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GK—coronary artery disease	4.23e-05	0.000662	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PFKM—coronary artery disease	4.23e-05	0.000662	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GATM—coronary artery disease	4.23e-05	0.000662	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB2—coronary artery disease	4.16e-05	0.00065	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	4.14e-05	0.000647	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	4.14e-05	0.000647	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	4.14e-05	0.000647	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—THBS1—coronary artery disease	4.13e-05	0.000647	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	4.11e-05	0.000643	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	4.09e-05	0.00064	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GCH1—coronary artery disease	4.04e-05	0.000632	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AK1—coronary artery disease	4.04e-05	0.000632	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	3.99e-05	0.000625	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	3.95e-05	0.000618	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	3.93e-05	0.000616	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MDH2—coronary artery disease	3.87e-05	0.000606	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLCD1—coronary artery disease	3.87e-05	0.000606	CbGpPWpGaD
Cefotetan—ALB—Metabolism—UGCG—coronary artery disease	3.87e-05	0.000606	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPAT—coronary artery disease	3.87e-05	0.000606	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAT—coronary artery disease	3.86e-05	0.000605	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TIMP1—coronary artery disease	3.86e-05	0.000605	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	3.84e-05	0.000601	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CETP—coronary artery disease	3.79e-05	0.000594	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PGM1—coronary artery disease	3.73e-05	0.000583	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IGF1—coronary artery disease	3.73e-05	0.000583	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	3.64e-05	0.00057	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	3.61e-05	0.000565	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PYGB—coronary artery disease	3.6e-05	0.000563	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CKB—coronary artery disease	3.6e-05	0.000563	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TFRC—coronary artery disease	3.6e-05	0.000563	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SERPINE1—coronary artery disease	3.54e-05	0.000554	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL6—coronary artery disease	3.52e-05	0.00055	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITGAV—coronary artery disease	3.4e-05	0.000532	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—KNG1—coronary artery disease	3.39e-05	0.000531	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PFKFB3—coronary artery disease	3.38e-05	0.00053	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTM2—coronary artery disease	3.38e-05	0.00053	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLIN1—coronary artery disease	3.38e-05	0.00053	CbGpPWpGaD
Cefotetan—ALB—Metabolism—DLAT—coronary artery disease	3.38e-05	0.00053	CbGpPWpGaD
Cefotetan—ALB—Metabolism—COX5B—coronary artery disease	3.38e-05	0.00053	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAUR—coronary artery disease	3.36e-05	0.000526	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLAT—coronary artery disease	3.34e-05	0.000523	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IFNA2—coronary artery disease	3.32e-05	0.00052	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLG—coronary artery disease	3.28e-05	0.000514	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—JAK2—coronary artery disease	3.28e-05	0.000514	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	3.22e-05	0.000503	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SULT1E1—coronary artery disease	3.21e-05	0.000502	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PRKCE—coronary artery disease	3.16e-05	0.000494	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SOD1—coronary artery disease	3.15e-05	0.000493	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	3.12e-05	0.000488	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AKR1B1—coronary artery disease	3.06e-05	0.000479	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HK2—coronary artery disease	3.06e-05	0.000479	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC27A1—coronary artery disease	2.93e-05	0.000459	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—APOB—coronary artery disease	2.9e-05	0.000455	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CPT1B—coronary artery disease	2.88e-05	0.00045	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LCAT—coronary artery disease	2.88e-05	0.00045	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	2.84e-05	0.000445	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—HGF—coronary artery disease	2.82e-05	0.000442	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA4—coronary artery disease	2.82e-05	0.000442	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CSF2—coronary artery disease	2.79e-05	0.000437	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	2.77e-05	0.000434	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PDHA1—coronary artery disease	2.73e-05	0.000427	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GCLM—coronary artery disease	2.73e-05	0.000427	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITGB3—coronary artery disease	2.68e-05	0.000419	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	2.64e-05	0.000414	CbGpPWpGaD
Cefotetan—ALB—Metabolism—TXNRD1—coronary artery disease	2.64e-05	0.000413	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP11B2—coronary artery disease	2.64e-05	0.000413	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CD36—coronary artery disease	2.63e-05	0.000412	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.62e-05	0.000411	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC22A3—coronary artery disease	2.6e-05	0.000407	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PPP2CA—coronary artery disease	2.6e-05	0.000407	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HADH—coronary artery disease	2.56e-05	0.000401	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ARNTL—coronary artery disease	2.56e-05	0.000401	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PRKCD—coronary artery disease	2.55e-05	0.0004	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.52e-05	0.000395	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	2.51e-05	0.000393	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.46e-05	0.000385	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	2.43e-05	0.000381	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA2—coronary artery disease	2.43e-05	0.00038	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLA2G2A—coronary artery disease	2.43e-05	0.00038	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX2—coronary artery disease	2.43e-05	0.00038	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MMP1—coronary artery disease	2.4e-05	0.000376	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCG5—coronary artery disease	2.4e-05	0.000376	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX4—coronary artery disease	2.4e-05	0.000376	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SULT1A1—coronary artery disease	2.4e-05	0.000376	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HK1—coronary artery disease	2.4e-05	0.000376	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	2.4e-05	0.000375	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HADHA—coronary artery disease	2.37e-05	0.000371	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAU—coronary artery disease	2.36e-05	0.000369	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTA1—coronary artery disease	2.35e-05	0.000367	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LPA—coronary artery disease	2.32e-05	0.000363	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—APOA1—coronary artery disease	2.3e-05	0.00036	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MAPK14—coronary artery disease	2.26e-05	0.000354	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLCB3—coronary artery disease	2.25e-05	0.000352	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	2.23e-05	0.00035	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA5—coronary artery disease	2.22e-05	0.000348	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FN1—coronary artery disease	2.19e-05	0.000343	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F2—coronary artery disease	2.19e-05	0.000343	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	2.19e-05	0.000343	CbGpPWpGaD
Cefotetan—ALB—Metabolism—P4HB—coronary artery disease	2.18e-05	0.000341	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS2—coronary artery disease	2.17e-05	0.000339	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	2.16e-05	0.000338	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLA2G1B—coronary artery disease	2.14e-05	0.000335	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.12e-05	0.000331	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.09e-05	0.000327	CbGpPWpGaD
Cefotetan—ALB—Metabolism—VCAN—coronary artery disease	2.02e-05	0.000316	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDOA—coronary artery disease	2e-05	0.000313	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.99e-05	0.000311	CbGpPWpGaD
Cefotetan—ALB—Metabolism—DCN—coronary artery disease	1.94e-05	0.000304	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IGF1—coronary artery disease	1.92e-05	0.000301	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	1.9e-05	0.000298	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDH2—coronary artery disease	1.89e-05	0.000296	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.84e-05	0.000288	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LIPC—coronary artery disease	1.84e-05	0.000288	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HBA1—coronary artery disease	1.84e-05	0.000288	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP2C19—coronary artery disease	1.84e-05	0.000288	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3C2A—coronary artery disease	1.84e-05	0.000288	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOC3—coronary artery disease	1.83e-05	0.000287	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SERPINE1—coronary artery disease	1.82e-05	0.000285	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LDLR—coronary artery disease	1.82e-05	0.000285	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.82e-05	0.000285	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTT1—coronary artery disease	1.8e-05	0.000281	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC9A1—coronary artery disease	1.8e-05	0.000281	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CETP—coronary artery disease	1.78e-05	0.000278	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GCLC—coronary artery disease	1.78e-05	0.000278	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SDC1—coronary artery disease	1.76e-05	0.000275	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS3—coronary artery disease	1.74e-05	0.000273	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—JAK2—coronary artery disease	1.69e-05	0.000265	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PSMB5—coronary artery disease	1.66e-05	0.00026	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PSMA6—coronary artery disease	1.66e-05	0.00026	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CTGF—coronary artery disease	1.62e-05	0.000254	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GOT2—coronary artery disease	1.61e-05	0.000252	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMGCR—coronary artery disease	1.61e-05	0.000252	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.55e-05	0.000243	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLCB1—coronary artery disease	1.48e-05	0.000231	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.45e-05	0.000227	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCA1—coronary artery disease	1.43e-05	0.000224	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GOT1—coronary artery disease	1.39e-05	0.000217	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GGT1—coronary artery disease	1.39e-05	0.000217	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VEGFA—coronary artery disease	1.25e-05	0.000196	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTP1—coronary artery disease	1.25e-05	0.000195	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARGC1A—coronary artery disease	1.23e-05	0.000193	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMOX1—coronary artery disease	1.23e-05	0.000192	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CAT—coronary artery disease	1.21e-05	0.00019	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOB—coronary artery disease	1.18e-05	0.000184	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB1—coronary artery disease	1.15e-05	0.00018	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTM1—coronary artery disease	1.15e-05	0.000179	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MAPK1—coronary artery disease	1.13e-05	0.000177	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LPL—coronary artery disease	1.12e-05	0.000176	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX1—coronary artery disease	1.1e-05	0.000172	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CD36—coronary artery disease	1.07e-05	0.000167	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPP2CA—coronary artery disease	1.05e-05	0.000165	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTHFR—coronary artery disease	1.01e-05	0.000158	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CA—coronary artery disease	9.8e-06	0.000153	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AGT—coronary artery disease	9.62e-06	0.000151	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOE—coronary artery disease	9.42e-06	0.000147	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA1—coronary artery disease	9.31e-06	0.000146	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.92e-06	0.00014	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARG—coronary artery disease	8.21e-06	0.000128	CbGpPWpGaD
Cefotetan—ALB—Metabolism—POMC—coronary artery disease	8.09e-06	0.000127	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT1—coronary artery disease	8e-06	0.000125	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NOS3—coronary artery disease	7.06e-06	0.00011	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTGS2—coronary artery disease	6.46e-06	0.000101	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CA—coronary artery disease	3.97e-06	6.22e-05	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AKT1—coronary artery disease	3.25e-06	5.08e-05	CbGpPWpGaD
